End Cash: The amount of cash held by the company for the given period.
Takeda Pharmaceutical Co. (TAK) had End Cash of $1.96B for the most recently reported fiscal quarter, ending 2023-12-31.
Income Statement Financials | |
$7.56B |
|
$718.90M |
|
$2.58B |
|
$4.98B |
|
$6.84B |
|
$713.41M |
|
$-296.85M |
|
$416.57M |
|
$416.57M |
|
$719.14M |
|
$719.14M |
|
$719.14M |
|
$719.14M |
|
$713.41M |
|
$1.95B |
|
3.14B |
|
3.17B |
|
$0.23 |
|
$0.23 |
|
Balance Sheet Financials | |
$16.52B |
|
$12.52B |
|
$80.20B |
|
$96.72B |
|
$15.52B |
|
$29.20B |
|
$35.35B |
|
$50.87B |
|
$45.85B |
|
$-16.77B |
|
$45.85B |
|
3.16B |
|
Cash Flow Statement Financials | |
$2.98B |
|
$-2.74B |
|
$-2.01B |
|
$3.63B |
|
End Cash |
$1.96B |
$-1.67B |
|
$358.24M |
|
$-1.89B |
|
-- |
|
Fundamental Metrics & Ratios | |
1.06 |
|
-- |
|
-- |
|
0.39 |
|
0.69 |
|
65.85% |
|
9.44% |
|
9.44% |
|
-- |
|
5.51% |
|
9.51% |
|
$2.15B |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.32 |
|
1.50 |
|
60.19 |
|
1.57% |
|
-4.29% |
|
0.74% |
|
0.96% |
|
$14.49 |
|
$0.68 |
|
$0.94 |